Powder: -20°C for 3 years | In solvent: -80°C for 1 year
L-(+)-Arabinose inhibits intestinal sucrase activity, thereby reducing sucrose utilization, and consequently decreasing lipogenesis.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
500 mg | 在庫あり | ¥ 10,000 | |||
1 g | 在庫あり | ¥ 11,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 7,000 |
説明 | L-(+)-Arabinose inhibits intestinal sucrase activity, thereby reducing sucrose utilization, and consequently decreasing lipogenesis. |
In vitro | L-(+)-Arabinose is associated with ribose-5-phosphate isomerase deficiency, an inborn metabolic error[1]. It selectively inhibits intestinal sucrase in a noncompetitive manner, thereby suppressing the increase in plasma glucose following sucrose consumption[1]. |
In vivo | L-(+)-Arabinose feeding reduced the weights of epididymal adipose tissue in rats. Moreover, plasma insulin and triacylglycerol concentrations were significantly reduced by dietary L-(+)-Arabinose[1]. L-(+)-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice[2]. |
分子量 | 150.13 |
分子式 | C5H10O5 |
CAS No. | 5328-37-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (399.65 mM), Sonication is recommended.
H2O: 400 mg/mL (2664.36 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
L-(+)-Arabinose 5328-37-0 Metabolism Endogenous Metabolite inhibit Inhibitor L-Arabinose L (+) Arabinose L(+)Arabinose inhibitor